Clinical Trial Update: The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypofractionated radiotherapy combined with immunotherapy for locally recurrent rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Recurrent Rectal Cancer | Phase 2 | Status: RECRUITING